Загрузка...
EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis
Tyrosine kinase inhibitor- (TKI-) based therapy revolutionized the overall survival and the quality of life in non-small-cell lung cancer (NSCLC) patients that have epidermal growth factor receptor (EGFR) mutations. However, EGFR is a highly polymorphic and mutation-prone gene, with over 1200 single...
Сохранить в:
| Опубликовано в: : | J Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104312/ https://ncbi.nlm.nih.gov/pubmed/32256580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1973241 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|